A physiologically based pharmacokinetic model for (-)-quinuclidinyl benzylate using nonlinear irreversible tissue binding parameters in rats

J. Ishizaki, E. Nakashima, K. Yokogawa, T. Nagano, T. Takayasu, F. Ichimura

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The disposition characteristics of (-)-quinuclidinyl benzylate (QNB) were investigated in rats, and a physiologically based pharmacokinetic model was established using its linear and nonlinear tissue binding parameters. The steady-state distribution volume (V(des)) and systemic clearance (CL(tot)) were comparable after iv administration of 325 ng/kg and 3.2 mg/kg, suggesting that QNB pharmacokinetics based on plasma concentrations is linear. However, tissue accumulation was observed in the heart, lung, muscle, and brain. This accumulation persisted for over 12 hr after the iv administration of 325 ng/kg [3H]QNB. Tissue binding parameters were determined after continuous infusion of QNB. Irreversible and nonlinear binding parameters were obtained in various regions of the brain and other tissues. Reversible equilibrium concentration ratios between tissue and plasma were determined after high-dose infusion. QNB concentrations in the plasma, heart, lung, muscle, and brain were predicted after the administration of 325 ng/kg or 3.2 mg/kg. There was reasonable agreement between the model predictions and the observed data.

Original languageEnglish
Pages (from-to)485-489
Number of pages5
JournalDrug Metabolism and Disposition
Volume20
Issue number4
Publication statusPublished - 1992
Externally publishedYes

Fingerprint

Pharmacokinetics
Rats
Tissue
Brain
Plasmas
Muscle
Myocardium
Lung

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

A physiologically based pharmacokinetic model for (-)-quinuclidinyl benzylate using nonlinear irreversible tissue binding parameters in rats. / Ishizaki, J.; Nakashima, E.; Yokogawa, K.; Nagano, T.; Takayasu, T.; Ichimura, F.

In: Drug Metabolism and Disposition, Vol. 20, No. 4, 1992, p. 485-489.

Research output: Contribution to journalArticle

Ishizaki, J, Nakashima, E, Yokogawa, K, Nagano, T, Takayasu, T & Ichimura, F 1992, 'A physiologically based pharmacokinetic model for (-)-quinuclidinyl benzylate using nonlinear irreversible tissue binding parameters in rats', Drug Metabolism and Disposition, vol. 20, no. 4, pp. 485-489.
Ishizaki, J. ; Nakashima, E. ; Yokogawa, K. ; Nagano, T. ; Takayasu, T. ; Ichimura, F. / A physiologically based pharmacokinetic model for (-)-quinuclidinyl benzylate using nonlinear irreversible tissue binding parameters in rats. In: Drug Metabolism and Disposition. 1992 ; Vol. 20, No. 4. pp. 485-489.
@article{9816e510b9ac459aa69cfb39898850ef,
title = "A physiologically based pharmacokinetic model for (-)-quinuclidinyl benzylate using nonlinear irreversible tissue binding parameters in rats",
abstract = "The disposition characteristics of (-)-quinuclidinyl benzylate (QNB) were investigated in rats, and a physiologically based pharmacokinetic model was established using its linear and nonlinear tissue binding parameters. The steady-state distribution volume (V(des)) and systemic clearance (CL(tot)) were comparable after iv administration of 325 ng/kg and 3.2 mg/kg, suggesting that QNB pharmacokinetics based on plasma concentrations is linear. However, tissue accumulation was observed in the heart, lung, muscle, and brain. This accumulation persisted for over 12 hr after the iv administration of 325 ng/kg [3H]QNB. Tissue binding parameters were determined after continuous infusion of QNB. Irreversible and nonlinear binding parameters were obtained in various regions of the brain and other tissues. Reversible equilibrium concentration ratios between tissue and plasma were determined after high-dose infusion. QNB concentrations in the plasma, heart, lung, muscle, and brain were predicted after the administration of 325 ng/kg or 3.2 mg/kg. There was reasonable agreement between the model predictions and the observed data.",
author = "J. Ishizaki and E. Nakashima and K. Yokogawa and T. Nagano and T. Takayasu and F. Ichimura",
year = "1992",
language = "English",
volume = "20",
pages = "485--489",
journal = "Drug Metabolism and Disposition",
issn = "0090-9556",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "4",

}

TY - JOUR

T1 - A physiologically based pharmacokinetic model for (-)-quinuclidinyl benzylate using nonlinear irreversible tissue binding parameters in rats

AU - Ishizaki, J.

AU - Nakashima, E.

AU - Yokogawa, K.

AU - Nagano, T.

AU - Takayasu, T.

AU - Ichimura, F.

PY - 1992

Y1 - 1992

N2 - The disposition characteristics of (-)-quinuclidinyl benzylate (QNB) were investigated in rats, and a physiologically based pharmacokinetic model was established using its linear and nonlinear tissue binding parameters. The steady-state distribution volume (V(des)) and systemic clearance (CL(tot)) were comparable after iv administration of 325 ng/kg and 3.2 mg/kg, suggesting that QNB pharmacokinetics based on plasma concentrations is linear. However, tissue accumulation was observed in the heart, lung, muscle, and brain. This accumulation persisted for over 12 hr after the iv administration of 325 ng/kg [3H]QNB. Tissue binding parameters were determined after continuous infusion of QNB. Irreversible and nonlinear binding parameters were obtained in various regions of the brain and other tissues. Reversible equilibrium concentration ratios between tissue and plasma were determined after high-dose infusion. QNB concentrations in the plasma, heart, lung, muscle, and brain were predicted after the administration of 325 ng/kg or 3.2 mg/kg. There was reasonable agreement between the model predictions and the observed data.

AB - The disposition characteristics of (-)-quinuclidinyl benzylate (QNB) were investigated in rats, and a physiologically based pharmacokinetic model was established using its linear and nonlinear tissue binding parameters. The steady-state distribution volume (V(des)) and systemic clearance (CL(tot)) were comparable after iv administration of 325 ng/kg and 3.2 mg/kg, suggesting that QNB pharmacokinetics based on plasma concentrations is linear. However, tissue accumulation was observed in the heart, lung, muscle, and brain. This accumulation persisted for over 12 hr after the iv administration of 325 ng/kg [3H]QNB. Tissue binding parameters were determined after continuous infusion of QNB. Irreversible and nonlinear binding parameters were obtained in various regions of the brain and other tissues. Reversible equilibrium concentration ratios between tissue and plasma were determined after high-dose infusion. QNB concentrations in the plasma, heart, lung, muscle, and brain were predicted after the administration of 325 ng/kg or 3.2 mg/kg. There was reasonable agreement between the model predictions and the observed data.

UR - http://www.scopus.com/inward/record.url?scp=0026734125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026734125&partnerID=8YFLogxK

M3 - Article

C2 - 1356722

AN - SCOPUS:0026734125

VL - 20

SP - 485

EP - 489

JO - Drug Metabolism and Disposition

JF - Drug Metabolism and Disposition

SN - 0090-9556

IS - 4

ER -